Skip to main content
Database: The Journal of Biological Databases and Curation logoLink to Database: The Journal of Biological Databases and Curation
. 2025 Oct 31;2025:baaf069. doi: 10.1093/database/baaf069

ROSBASE1.0: a comprehensive database of reactive oxygen species (ROS): categorization of cell organelles, proteins, taxonomy, and diseases based on ROS-related activities

Sharayu Ghodeswar 1, Debashree Bandyopadhyay 2,
PMCID: PMC12576790  PMID: 41171287

Abstract

The reactive oxygen species (ROS) produced by various cell organelles often relate to pathophysiology or pathogenesis. Information on ROS-producing, scavenging, and regulatory proteins from various taxonomic kingdoms and organelles, enzyme classes, and diseases was scattered across the literature. Consolidation of all information would facilitate the researchers to understand ROS-related pathology and possible therapeutics. For the first time, we developed a secondary database, ROSBASE1.0, consolidating ROS protein features, taxonomy, diseases, and interactome data. Data sources were PubMed, UniProt, STRING, and Google Scholar databases. Notably, 81.5% of the reported data were experimentally curated. The ROS mechanism was elucidated for 79.2% of entries based on text-mining from the literature. A total of 2494 experimentally annotated entries (UniProt IDs) were curated in the database. Multiple PDB IDs correspond to individual UniProt IDs, resulting higher number of PDB entries (n = 9174). The database reported 2447 genes, 16 cell organelles, 395 organisms, and 218 disease entries (corresponding to 143 proteins) classified into 14 categories. In this database, proteins were classified based on taxonomic kingdoms, enzyme classes, and diseases. The keywords to search the database were—UniProt ID, PDB ID, cell organelle, organism name, and gene name. The tabular results depict all the above features, in addition to the interactome network. The database (https://rosbase.bits-hyderabad.ac.in/) for the first time quantitatively demonstrated the preferences of lower organisms towards ROS-scavenging versus ROS production by higher organisms. Categorization of different diseases according to their ROS involvement was also reported here for the first time. This database could potentially serve as a user guide to ROS Biology.

Introduction

The highly reactive oxidizing agents, containing at least one atom of oxygen and unpaired electrons, are referred to as reactive oxygen species (ROS), e.g. singlet hydroxyl, singlet oxygen, hydroperoxyl radicals, [1, 2], hydroxyl radicals (OH), hydrogen peroxide (H2O2), superoxide radical anion (O2), ozone (O3) [3], etc.; these are the byproducts of incomplete molecular oxygen decomposition. ROS is an important component for cellular processes at low to moderate concentrations, but could be lethal due to overproduction. Thus, ROS can be deleterious to cells but can also be an integral part of cell survival and adaptive signalling [4]. Considering the dual effects of ROS, previously termed ‘oxidative stress’ has been redefined as ‘oxidative eustress’ and ‘oxidative distress’ [5, 6]. ‘Oxidative eustress’ was defined as adaptive cell responses to ROS that induce allostasis, followed by the reversible and site-specific oxidation or reduction of protein-cysteine. ‘Oxidative distress’ was defined as overproduction of ROS beyond the beneficial physiological range, thus leading to cell damage and disease. A few examples of ‘oxidative distress’ are, ROS induced cell damage by altered signalling pathways [7, 8] cancerous growth by DNA damage and altered cell signalling [9], ROS-induced pathological stages, such as cardiovascular diseases [10], myocardial infarction/ischaemic myocardium [11], metabolic syndrome, insulin resistance, obesity, diabetes [12], neurodegenerative diseases [13], etc. The most common source of ROS is the respiratory complexes I and III in mitochondria, through which most of the electrons are transported to the terminal electron acceptor, molecular oxygen. Recently, unconventional sources of ROS in mitochondria were identified, which were isopotential groups of two classes, NADH/NAD and CoQH2/CoQ ( Fig. 1 of [4]). These groups can produce more ROS than Complex I. Around 0.2%–2% of the electrons in electron transport chain (ETC) leak out and form ROS molecules, such as superoxide and hydrogen peroxide [14]. The mitochondrial permeability transition pores contribute to maintaining mitochondrial ROS homeostasis [15]. Mitochondrial uncoupling proteins (UCPs) play an important role in controlling ROS production by modulating the proton gradient across the inner mitochondrial membrane. UCP2 and UCP3 decrease mitochondrial membrane potential through mild uncoupling, effectively reducing the electron leak that drives superoxide generation and its consequences [16–18]. UCPs could also regulate oxidative stress through calcium transport and lipid hydroperoxide export [19–21]. In addition to respiratory complexes, a few dehydrogenases in mitochondria generate ROS, such as Alpha-ketoglutarate dehydrogenase (α-KGDH), pyruvate dehydrogenase (PDH), and branched-chain α-keto acid dehydrogenase (BCKDH). All these complexes share similar structures and belong to the Alpha ketoacid dehydrogenase complex family, catalyse the oxidative decarboxylation of specific α-ketoacids [22]. α-KGDH and PDH are involved in both ROS production and scavenging. The α-KGDH produces ROS, especially under NADH/NAD⁺ imbalance, promoting mitochondrial dysfunction and Parkinson’s disease [23]. Under low NADH/NAD⁺ conditions, both KGDH and PDH produce ROS via reverse electron transfer (RET), thus amplifying RET from complex II to I [24, 25]. Under metabolic stress, PDH is inhibited by PDH kinase [26], thus reducing mitochondrial respiration and ROS production. ROS can be produced in many more cellular compartments, other than mitochondria, such as cytoplasm, membranes, endoplasmic reticulum, lysosomes, peroxisomes, etc. [27]. The most common ROS species detected in the cell are hydrogen peroxide (H2O2), superoxide (O₂), hydroxyl radicals (OH), and singlet oxygen (1O2), produced in different cellular compartments (Table 1). For example, superoxide radical (O₂) is produced within mitochondria by Complex I and Complex III and scavenged to molecular oxygen (O₂) by superoxide dismutase (SOD) [28]. Hydroxyl radicals (OH) are produced in mitochondria and cytosol due to the loss of electrons from water molecules [29]. Hydrogen peroxide (H₂O₂) is formed in mitochondria, cytosol, and nucleus and converted to water and oxygen, mainly, by the catalase enzyme [30]. Singlet oxygen (¹O₂) is produced in the chlorophyll due to the photosensitization of ground-state oxygen (³O₂) [31]. The hydroxyl radical (•OH) reacts with carbon and molecular oxygen to produce the peroxyl radical ROO that undergoes a chain reaction to produce hydroperoxide ROOH and alkoxyl radical RO [32]. The term ‘ROS’ also, generously, includes nitrogen-containing reactive species, termed as reactive nitrogen species; e.g. nitric oxide (NO), anion (NO), etc. The ROS molecules are linked to various redox and cell signalling pathways, thus contributing to various cellular activities and cellular homeostasis [14, 15, 33]. In fact, ROS (particularly, H2O2) plays a central role in the ‘Redox Code’ that regulates biological operations; the term was introduced analogous to ‘genetic code’, ‘epigenetic code’, ‘histone code’, etc. [34]. ‘Redox code’ consists of four principles, briefly, those are, (i) use of reversible electron carriers, namely NAD+/NADH and NADP+/NDAPH to provide organization of metabolism, that constitutes activation and deactivation of redox cycles (redox sensing), (ii) metabolism is linked to protein tertiary structures, interaction network, activities, etc., through kinetically controlled redox switches [various cysteine post-translational modifications (Cys-PTMs)] in the proteome, (iii) redox sensing, especially involving H2O2, support spatiotemporal sequencing in differentiation and life cycles of cells and organisms, and (iv) redox networks form an adaptive system to respond to the environment from sub-cellular organelles to the levels of cell and tissue organization. Hydrogen peroxide (pivotal in ‘Redox Code’) levels within the cell are predominantly regulated by Peroxiredoxins (Prxs), a ubiquitous family of cysteine-dependent peroxidase enzymes [35–39]. At higher exposure to H₂O₂, the cysteine residues of Prxs undergo oxidation to sulfinic acid, causing temporary inactivation of the enzymes [40–42].

Figure 1.

Figure 1.

Schematic diagram of Cys-PTMs involved in ROS-related activities: ROS scavenging (—|) and ROS producing (→).

Table 1.

Production of ROS in different cellular compartments.

ROS species Source Reactions
Superoxide radical (O2) [28] Mitochondria associated with Complex I and Complex III O2 →e + O−2
M(n+1)+−SOD + O−2 → Mn+−SOD + O2 (superoxide dismutase)
(Mn- Cu (= 1); Mn (= 2); Fe (= 2); Ni (= 2))
Hydroxyl radical (OH) [29] Mitochondria, cytosol H2O →e + OH (UV/x-rays)
Mn+−SOD + O−2 + 2H+ → M(n+1)+− SOD + H2O2
Hydrogen peroxide (H2O2) [30] Mitochondria, cytosol, nucleus 2H2O2 → 2 H2O + O2  (catalase)
2GSH + H2O2→ GS–SG + 2H2O (Glutathione peroxidase)
Singlet oxygen (1O2) [31] Chlorophyll 3O21O2 (Photosensitizer)

ROS-related protein categories

ROS-related protein activities are diverse, ranging from ROS production, scavenging, and regulatory activities. Here, we categorized ROS-related proteins into four groups, namely, ROS-producing, ROS-scavenging, ROS-producing-and-scavenging, and ROS-indirect involvement.

ROS-producing

ROS production is mediated by enzymes such as NADPH oxidase (NOX) and other mitochondrial enzymes. Specific examples are, (i) macrophage proteins interact with the NOX subunit NCF1 and activate NOX-dependent ROS generation as a defence mechanism, e.g. against sepsis [43], (ii) Vasculostatin-40 enhances the binding of Gram-negative bacteria and prompts macrophages to generate ROS (microbicidal functions) [44], (iii) the ERO1-like protein facilitates ROS formation during protein disulfide production by transferring electrons to molecular oxygen [45], (iv) Thrombospondin-1 enhances ROS production in endothelial cells and contributes to cellular aging [46–48], and (v) in the hypothalamus region, Leptin protein pro-opiomelanocortin (POMC) neurons increase neutrophil chemotaxis and oxygen radical release [49].

ROS-scavenging

ROS scavenging is mediated by antioxidant enzymes, such as SOD, catalase (CAT), peroxidase (GPX), etc. Specific examples are, (i) catalase activates peroxisomal oxidases to convert hydrogen peroxide into water and oxygen [50], (ii) SOD neutralizes toxic radicals [51, 52], (iii) aquaporin-8, regulates ROS signalling by absorbing hydrogen peroxide [53].

ROS-producing-and-scavenging

Some proteins exhibit dual roles of ROS production and scavenging and maintain cellular homeostasis, few examples are cited. (i) Glycerol-3-phosphate dehydrogenase that balances ROS by shuttling mitochondrial glycerol-3-phosphate and maintains cellular NADH/NAD + ratio [54], (ii) cellular communication network factor 1 (CCN), produces ROS and also contributes towards the positive feedback loop by oxidative stress [55], (iii) Parkinson’s disease-associated protein, PARK7 homolog, maintains mitochondrial ROS and glucose homeostasis in pancreatic islets in response to age and nutrition, and protects pancreatic beta cells from inflammation or cytotoxicity-induced cell death [56].

ROS-indirect-involvement

ROS is crucial for maintaining cellular homeostasis through a cascade of reactions, chaperone activities, etc. A few examples, (i) thioredoxin reductase-2 regulates mitochondrial redox homeostasis and ROS levels [57], (ii) mitochondrial protein adenylyl transferase, SelO, maintains redox haemostasis by contributing towards Adenylation (involving adenosine 5’-monophosphate) and protein S-glutathionylation; these processes modulate several cellular oxidative stress responses [58], (iii) PARK7 is also indirectly involved in ROS activity by chaperoning copper ions to the active site of SOD protein [59], (iv) peroxisomal heat shock protein acts as chaperone at elevated temperatures and generates ROS [60], and (v) early secretory antigenic target triggers a cascade of events—activation of ERK—p38 mitogen-activated protein kinase signalling pathways—ROS production [61].

Involvement of cysteine amino acid in ROS activity

Redox modifications, mainly the reversible oxidation of cysteine residues in proteins, are critical for preventing oxidative distress. Those act as redox switches, allowing proteins to sense and adapt to oxidative signals, a priori, permanent damage, thereby maintaining cellular balance [62–64]. Most of the ROS-associated proteins have cysteine (Cys) at their active sites. Different post-translational modifications of Cys, namely, metal binding [65, 66], disulfide [67], S-nitrosylation [68], glutathionylation [68], and other oxidative post-translational modifications (OxPTMs) [69], are involved with ROS in various ways (Fig. 1). Cysteine metal-binding was observed in iron–sulphur clusters, haem, and zinc finger motifs, which maintain cellular redox balance and protect against oxidative stress [65]. S-oxidation, S-glutathionylation, and S-nitrosylation of Cys, produce ROS in mitochondria; whereas S-glutathionylation prevents oxidative stress by mitigating ROS production in key sources, such as α-KGDH and PDH, etc. These dehydrogenases are inhibited by ROS as a consequence of OxPTMs such as S-glutathionylation and S-nitrosylation that result in reduced NADH and ATP production, accumulation of TCA intermediates [70]. S-nitrosylation of the lipoic acid moiety on KGDH inhibits its enzymatic activity, thereby reducing NADH production and downstream electron flux, ultimately decreasing ROS generation from the respiratory chain [71]. Similarly, S-glutathionylation of KGDH also results in its reversible inhibition, thus protecting against irreversible oxidative damage during oxidative stress [72]. S-nitrosylated proteins in mitochondria (SNO-proteins) inhibit respiratory Complex I, ROS production, and a series of mitochondrial processes [73]. OxPTM includes ROS-mediated oxidation of cysteine thiol (−SH) to sulfenic acid (−SOH). Sulfenic acid can be further oxidized to sulfinic acid (SO₂H) and sulfonic acid (SO₃H). These modifications are often reversible and involved in signalling that can alter protein function or act as a precursor to further oxidative modifications [74–76]. However, only selective cysteine residues undergo ROS-mediated modifications depending upon their physiological requirements and local redox environment.

Methodology

The information on ROSBase1.0 was gathered from different databases, namely, UniProt (www.uniprot.org), PDB (www.rcsb.org), PubMed (https://pubmed.ncbi.nlm.nih.gov/), and STRING (https://string-db.org/).

ROS-related data curation from different databases

UniProt database

The ROS-related data were primarily curated from the UniProt database dated 17.04.2025. The search was exhaustive for the given keywords ‘reactive oxygen species’.

The initial search resulted in 86 133 entries. The search results were further filtered using ‘Reviewed’ (experimental and computer-predicted) keyword, which returned 2494 protein entries. Two viral proteins were excluded due to the ambiguity of the ROS source, whether it is from the host or the virus. Hence, a total of 2492 UniProt IDs were considered. The customized search results were downloaded based on the Application Programming Interface (API) of UniProt, with the following features, protein name, gene name, UniProt ID, organism, function, sub-cellular location (cell organelle), PubMed ID, and PDB ID.

PubMed database

A total of 12 469 PubMed IDs were retrieved from the abovementioned UniProt API, and 9766 articles were downloaded from the PubMed database. The articles not available were downloaded using PMC IDs from the PMC database (n = 861). A few more articles were downloaded from respective journal homepages (n = 148). A total of 921 articles could not be downloaded due to restricted permissions. Hence, a total of 10 775 articles were obtained out of 12 469 PubMed IDs.

Text mining of the research articles

The downloaded articles were subject to text mining using an in-house Python script. The Python modules implemented in this code were: regular expression (regex/re) (pattern matching); glob (finding files in the directory); csv (handling comma-separated-value files); fitz (extracting text from PDF); and tqdm (indicating progress bar). A list of PDF filenames was extracted using the glob module. Opening and reading each PDF file, progress monitoring within a for loop was performed using tqdm module. The page numbers were extracted using fitz module. A nested ‘for loop’ was iterated over the number of pages (per PDF file) to extract text from each page. The search keywords within the page were ‘Reactive’, ‘oxygen’, and ‘species’, using regular expressions (regex module). Approximately, ±500 characters were collected around the matched keywords and the contextual snippet was saved in a CSV file, including the filename and page number. The saved CSV file stored ROS-related protein information, diseases, protein functions, and mechanisms. All the data gathered from 6082 articles were compiled into a ‘JSON’ file.

STRING database

The STRING database was searched for interactome data, using UniProt IDs (n = 2494), resulting in 1951 entries.

Each of these string entries corresponds to a single ‘central protein’ in the current study, in contrast to the STRING database, where interactions of multiple proteins with multiple partners are described. We have filtered a single protein (entry) and generated the interactome network around it. All the partners, corresponding to that single protein, were exported as a tab-separated-value (TSV) file. Each TSV file was imported into the Cytoscape software (v 3.10.2) for display. The central protein and the interacting partners were colored differently, and the image was saved as a picture (.png) format. All these images were saved in a static folder. Image names and interactome IDs were added in two separate columns in the ‘JSON’ file that completes the ‘ROSbase’ database. The flowchart of the database is shown (Fig. 2).

Figure 2.

Figure 2.

Flowchart of ROSBase curation.

Web server development

The ROSBase1.0 database web server was developed using the Flask lightweight web framework on the Ubuntu 20.04 platform, implemented in Python. This web server offers a user-friendly graphical user interface (GUI) to search the database. The following software packages, environments, and libraries were installed for this web application, namely, Python3 (v 3.8.10), Flask (v 2.3.2), Gunicorn (v 21.2.0), and Nginx (v 1.18.0). The deployment process included Flask application setup, Green Unicorn (Gunicorn) and Nginx configuration, and ‘systemd’ service unit creation. Nginx, the high-performance web server and reverse proxy, forwards the requests from clients to the local Flask application, recruited as a production server by Nginx. The Flask production server ensures stability, scalability, and optimized performance. Gunicorn Web Server Gateway Interface communicates between the HTTP server front end and back end. The application was encrypted with SSL certificates (https://certbot.eff.org/), firewall settings were adjusted; accessibility and functionality were verified.

Backend of the webserver

The backend of the ROSBase server was based on an in-house Python code, input to that is a user-defined query (any one of the following—protein names, UniProt IDs, PDB IDs, cell organelles, or gene names) and output is ROS-related information from the JSON file. There was a check whether the query was present in the database; if ‘yes’, the results would be returned from the JSON file, if ‘no’, an error message would be displayed with termination (Fig. 3). The result returns the following features in tabular form, Protein name, UniProt ID, PDB ID, gene name, function, ROS-associated mechanism, diseases, and interactome data (provided the string ID was available for that particular entry). If String ID was not available it would be redirected to the STRING homepage. The interactome image would only be displayed for a single output result and not for multiple outputs. For example, the query name, mitochondria, yielded multiple outputs and the Cytoscape images or STRING ID would not be displayed.

Figure 3.

Figure 3.

Workflow (integrating backend and frontend) of ROSBase1.0 webserver.

Results and discussion

Data statistics of ROSBase

The database consisted of 2494 entries (UniProt IDs), 2182 genes, 6959 PDB IDs, and 10 775 PubMed entries. The gene names were fewer than the total number of entries because some genes were not reported corresponding to the proteins. The number of PDB IDs exceeded the number of entries due to multiple crystal structures for certain proteins. A total of 17 cell organelles, 262 organisms, and 243 diseases (14 categories) were reported in the database. All the taxonomic groups were well represented in the current study—Animalia (n = 1569), Plantae (n = 359), fungi (n = 194), Protista (n = 38), and bacteria (n = 334). The diseases were only represented for Homo sapiens (n = 143).

Validation of the data

  • (i) UniProt entries:

  • Out of 2492 UniProt entries (protein sequences), 1469 sequences were identified at the protein level, using complete or partial Edman sequencing and identification by mass spectrometry, X-ray, and Nuclear Magnetic Resonance (NMR) structure, and detection of the proteins by antibodies (www.uniprot.org). A total of 563 sequences were derived from the transcripts, experimentally obtained from mRNA expression. The remaining 462 entries were computationally predicted. Thus, 81.5% of the entries in the database were authenticated by experiments.

  • (ii) From literature:

  • A total of 10 775 articles were downloaded from PubMed and other sources. Using text-mining, only 6082 articles have produced information based on the keywords, ‘Reactive’, ‘oxygen’, and ‘species’. These 6082 articles correspond to 1974 UniProt entries. Thus, for 79.2% of entries, the ROS mechanism was elucidated.

ROS-related protein categories

ROS-related proteins were broadly categorized into four different groups: (i) ROS-scavenging (998 entries), (ii) ROS-producing (525 entries), (iii) both ROS-producing and scavenging (201 entries), and (iv) indirectly involved with ROS-proteins (770 entries). The largest group consisted of the ROS scavenging category, presumably because cells protect themselves against oxidative damage.

ROS-associated proteins were further classified based on cell organelles, enzyme class, taxonomy, and diseases.

Cell organelles

All the 2494 entries were classified into 16 cell organelles that were involved with ROS [77]. Many of these cell organelles were engaged in cross-talk via physical or functional contacts (known as membrane contact sites (MCSs), crucial for the redox activity of the cell [78]. The physical contacts between the outer membrane of the mitochondria and the endoplasmic reticulum, known as mitochondria-associated membranes (MAMs) [79], transfer metabolites, such as lipids, proteins, etc. [80]. These MCS and MAMs are enriched with redox-regulatory proteins. Similarly, peroxisomes and mitochondria also crosstalk by exchanging molecules. For example, the NADH produced in peroxisomes, as a part of beta-oxidation, is transported back to mitochondria for oxidation [80]. All these ROS-related processes were physiologically essential to regulate homeostasis.

Cytoplasm contains the maximum entries (747 entries) and is identified as one of the main contributors of ROS in this database (Fig. 4). The main sources of ROS in the cytoplasm are dual oxidases (DUOXI-II) and transmembrane NOXs, which produce O2 by reducing molecular oxygen [81]. Mitochondria are the second-largest (405 entries) source of ROS in the database, where electrons escape from the final electron acceptor molecule, oxygen, and leak out from the ETC [82]. The third largest contributor of ROS in the database are nucleus, DELLA protein RGL2 (GRAS family protein 15) that promotes stress tolerance by acting on the ROS scavenging mechanism and prevents stress-induced ROS accumulation [83].

Figure 4.

Figure 4.

Data statistics for cell organelles. ‘Not reported’ sub-cellular location, termed here as a separate category is not shown.

Kingdom classification

The database was further classified based on the domain classification [84, 85]. The current study has non-zero entries for only two domains, Eukaryota (n = 2160) and Bacteria (n = 334). Domain Eukaryota consisted of Protista (n = 38), fungi (n = 194), Plantae (n = 359), and Animalia (n = 1569). The details of the taxonomy per kingdom were represented schematically (Fig. 5).

Figure 5.

Figure 5.

The taxonomic classification of the database. Numbers of entries in each category are shown.

Kingdom Animalia has seven phyla and thirteen classes. Kingdom Plantae has two phyla, Bryophyta (n = 1) and Tracheophyte (n = 356); all Tracheophyte belong to angiosperm class.

All the entries under the taxonomic classification exhibited ROS-related activities, although at different degrees. The Animalia kingdom hosted almost equal percentages of the ROS-producing, and ROS-scavenging proteins, and a least from ROS-indirect involvement (Fig. 6). In contrast, Kingdom Plantae has a significantly lower percentage of ROS-producing proteins (almost half) compared to ROS-scavenging proteins; although ROS-scavenging and ROS-indirect involvement entries were equivalent in number. These observations indicated the major involvement of ROS-scavenging and ROS-mediated entries in plants. A few examples of ROS-mediated physiology in plants—(i) In Arabidopsis thaliana (Mouse-ear cress), secreted transmembrane peptide 4 (Phytocytokine STMP4) regulates physiological and antimicrobial activities by inhibiting growth and modulating the response to ROS [86], (ii) 3-hydroxyacyl- [acyl-carrier-protein] dehydratase is involved in photorespiration, plant morphogenesis, and balances ROS levels in Solanum lycopersicum (Tomato) [87].

Figure 6.

Figure 6.

Heatmap of four different ROS-related categories in taxonomic groups based on domain [84, 85].

ROS producing

As per this database, Animalia produce the maximum amount of ROS, in terms of the number of ROS-producing entries (n = 357), presumably due to the complexity of the metabolic pathways and immune responses (e.g. oxidative bursts in macrophages, etc.). ROS production in Plantae (n = 95) is mainly related to stress signalling [88]. In bacteria (n = 16), ROS is generated as a byproduct of metabolic processes, such as stress response [89]. Fungi (n = 49) and Protista (n = 5) produce a minimum amount of ROS, as observed in this database.

ROS scavenging is common across all organisms to mitigate ROS toxicity; highest in Animalia (n = 469), indicating the presence of robust antioxidant systems (e.g. catalase, glutathione peroxidase, etc.), followed by Plantae (n = 126), ROS scavenged via both enzymatic and non-enzymatic mechanisms [90]. ROS-scavenging is moderate to low in other kingdoms, bacteria (n = 290) and fungi (n = 96), and Protista (n = 19), mostly due to their stress adaptation mechanisms.

Both producing and scavenging of ROS are prominent in Animalia (n = 181), suggesting the presence of multifunctional ROS regulators, in comparison to the other kingdoms, Plantae (n = 12), fungi (n = 5), and Protista (n = 3).

Indirect involvement of ROS modulates different types of functional activities, such as redox signalling, transcription factors, chaperoning, etc. This indirect involvement of ROS is mostly observed in Animalia (n = 562), followed by bacteria (n = 28) and Plantae (n = 126), presumably due to complex signalling networks, compared to fungi (n = 44) and Protista (n = 11).

Enzyme class

The database was further classified based on enzyme classes (Fig. 7). The majority of the protein entries fall in the non-enzymatic class (n = 1167). Enzyme class 1, oxidoreductase (n = 692), exhibited the second highest number of entries, presumably because enzymes involved in redox activities are also associated with ROS [91]. Enzyme class 2, transferases, has the next largest number of entries (n = 302), which catalyse the transfer of functional groups across the molecules. Glutathione S-transferase is an example that catalyses peroxide to water or alcohol and oxidizes glutathione (GSH) to GSSG [92]. Enzyme class 3, hydrolases (n = 186), catalyse hydrolysis reactions. Epoxide hydrolase 1 (Ephx1) or microsomal (mEH) is an example that catalyses detoxification of genotoxic substances and scavenges ROS [93]. Enzyme class 4, lyases (n = 32), catalyses the lysis of bonds; an example of ROS involvement of lyase—ATP citrate lyase (ACLY) depletion elevates the intracellular ROS concentration [94]. Enzyme class 5, isomerases (n = 67), catalyses isomerization reactions. An example of ROS involvement of isomerase—protein disulfide isomerase, a thioredoxin family protein, is involved in redox-dependent activities, such as TNFα-dependent angiogenesis and indirect ROS production [95]. Enzyme class 6, ligases (n = 12), catalyses the joining of two molecules to form a single molecule. An example of ROS involvement of ligase—the E6AP E3 ubiquitin ligase, involved in the control of cell development and stress response, thus modulating cellular ROS levels [96]. To note, the E3 ubiquitin-protein ligase is omnipresent across Animalia and Plante kingdoms. For example, E3 ubiquitin-protein ligase, parkin, (from Kingdom Animalia, Mus musculus (mouse)) regulates cyclin E during neuronal apoptosis, which enhances cell viability and protects against oxidative stress [97]. Whereas E3 ubiquitin-protein ligase, (from Kingdom Plante, Arabidopsis thaliana) increases ABA-induced stomatal closure, ROS generation, and drought tolerance [98]. Enzyme class 7, translocases (n = 34), catalyses the movement of molecules or ions across cell membranes. An example of ROS involvement of translocase—peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α) enhances antioxidant gene expression thus reducing ROS formation in endothelial cells, and subsequent reduction in cell death [99].

Figure 7.

Figure 7.

Distribution of enzyme classes in this database. Numbers of entries in each category are shown. The reactions catalysed by the respective enzyme classes are shown on the right-hand side.

ROS-related diseases in the database

The database has 143 protein entries related to diseases. Individual protein entries were often associated with more than one disease, resulting in 218 disease entries. Based on the disease anatomy, these entries were categorized into 14 groups (Fig. 8). The disease categories included neurological disorders (n = 49), genetic and chromosomal disorders (n = 26), metabolic and endocrine disorders (n = 21), autoinflammatory and immunological disorders (n = 24), musculoskeletal and dermatological disorders (n = 19), cancer and tumour syndromes (n = 17), mitochondrial disorders (n = 11), haematological and connective tissue disorders (n = 11), ophthalmological disorders (n = 7), developmental disorders (n = 7), renal and urinary disorders (n = 6), cardiovascular disorders (n = 8), gastrointestinal and digestive disorders (n = 10), and respiratory system disorders (n = 2).

Figure 8.

Figure 8.

Distribution of disease categories (based on disease anatomy) in this database. Numbers of entries in each category are shown.

These diseases were further characterized based on ROS related four protein categories. Three disease categories, genetic and developmental diseases, brain and nervous system, and immunological disorders, were the most frequently involved in ROS production and scavenging. A few examples are, (i) paragangliomas 1, an autosomal dominant disorder, under oxidative stress, produces ROS and contributes to the formation and progression of tumours [100], (ii) ciliary dyskinesia (CILD48), an immunological or auto-immune disease, manifests impaired respiratory cilia motility leading to chronic respiratory problems and recurrent infections, affected by ROS [101], and (iii) ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, a brain and nervous system disorder, under oxidative stress, damages neurons and contributes to the neurodevelopmental abnormalities [102].

As mentioned above, one protein may be linked to multiple diseases. This has been demonstrated through the involvement of one UniProt ID in multiple diseases or disease categories (Fig. 9a). UniProt IDs corresponding to different disease categories are shown (Fig. 9b). Here, we have illustrated it using two examples, (i) Tauopathy: microtubule-associated protein tau is unable to bind microtubules in Tauopathy (a group of neurodegenerative disorders characterized by the pathological accumulation of abnormally phosphorylated tau protein in the brain) [103]. In this study, we demonstrate involvement of tau protein (UniProt ID: ‘P10636’) in multiple neurological disorders such as alzheimer’s, Parkinson’s, frontotemporal dementia, pick disease, corticobasal degeneration, and progressive supranuclear palsy 1. Tau protein (UniProt ID: P10636) in this database corresponds to eight diseases belonging to the ‘neurological disorder’ category (Fig. 9a).

Figure 9.

Figure 9.

(a) Disease categories per protein entry (UniProt ID). (b) Pie chart representation of each disease category and corresponding UniProt IDs.

(ii) The second example is disorder in platelet-derived growth factor receptor beta (PDGFRβ) (UniProt ID: ‘P09619’). This cell surface protein is involved in various cellular activities upon binding to PDGF ligands [104], including blood vessel formation by guiding the recruitment of pericytes and smooth muscle cells [105], kidney and cardiovascular development [106], etc. Mutations or chromosomal rearrangements activate abnormal PDGFRβ levels. It promotes proliferation of connective tissues, leading to chronic myelomonocytic leukaemia, juvenile myelomonocytic leukaemia, and acute myeloid leukaemia [107], myeloproliferative eosinophilic syndrome through clonal eosinophil expansion [108], idiopathic basal ganglia calcification 4 [109], etc. Germline mutations in PDGFRβ can produce benign tumours in skin, muscle, and bone in infantile myofibromatosis 1 [110], and Kosaki overgrowth syndrome, a developmental disorder, marked by tissue overgrowth and intellectual disability [111]. In this study, UniProt ID: ‘P09619’ was identified under two disease categories, namely, ‘Cancer and Tumors Syndromes’ and ‘Autoinflammatory and Immunological disorders’ (Fig. 9a).

The categorization of disease-induced ROS activities was not reported earlier; to the best of our knowledge, this is documented in this database for the first time. Documentation of these ROS-related diseases could presumably aid researchers in improving ROS-related therapeutics.

Discussion

Role of Cys-PTMs on ROS activities

As discussed above, site-specific oxidation or reduction of protein-cysteine plays an important role in ‘Oxidative eustress’, mediated via adaptive cell responses to ROS. Literature reports had also indicated the role of S-Glutathionylation and S-nitrosylation in inhibiting dehydrogenases, such as, alpha-KGDH, PDH, etc. Protein redox switches, i.e. Cys-PTMs, were mentioned as one of the four pivots of the ‘Redox Code’. Here, in this database, Cys-PTMs related to ROS are consolidated for a total of 1985 cysteine entries; the maximum of those are metal-binding (Table 2). Twelve different types of cysteine metal-binding are recorded (Table 3). The highest number of metal-binding cysteines was observed in Fe(II), predominantly present in peroxidase (96), and catalase (23). Fe(II) scavenges ROS (mainly H2O2) via Fenton reaction (Fe²⁺ + H₂O₂ → Fe³⁺ + •OH + OH) [112]. Zn(II) ion (n = 192) are part of Zn-superoxide dismutase (Zn-SOD; n = 39), an antioxidant enzyme, that reduces superoxide (O2) to peroxides (H2O2) [113]. Out of 13 K(I) ions, 12 belong to ascorbate peroxidase, which reduces peroxides to water [114, 115]. Out of 18 Mn(II) ions, six are part of Mn-superoxide dismutase, thus involved in scavenging ROS [116]. Mo(II) (n = 98) ions are involved in superoxide production during purine metabolism [117]. A total of 81 Mo(II) ions are part of ‘Protein-methionine-sulfoxide reductase’ (Msr), a thiol-dependent oxidoreductase, that reduces oxidized methionine using thioredoxin [118]. Iron–sulphur clusters are the co-factors that mediate electron transfer across the mitochondrial respiratory complexes and participate in ROS production by the Complexes I, II, and III [119]. In this database, 25 2Fe–2S and 5 4Fe–4S are reported.

Table 2.

Statistics of cysteine post-translation modifications in this database.

Cysteine-post translational modifications (PTM) Number of entries Reactions
Metal-binding (−S-Mn+) 1113 Prot-SH + M+ → Prot-S—M
Disulfide (−S = S−) 761 Prot-SH + P'SH → Prot-S = S-Prot' + H2O
Palmitoylation (−S-(CH2)nCOOH) 55 Prot-SH + -(CH2)nCOOH → Prot-S-(CH2)nCOOH
Sulfenylation (−SOH) 27 Prot-SH + H2O2 → Prot-SOH + H2O
Nitrosylation (−SNO) 18 Prot-SH + NO• → Prot-SNO + H+
Thioester (−S-COR) 8 Prot-SH + -COR → Prot-S-COR
Glutathionylation (−SSG) 3 Prot-SH + GSSG → Prot-SSG + GSH

Table 3.

Twelve different types of Cys-PTM, metal binding modifications present in this database.

Cysteine PTM metal modifications Number of entries Proteins involved (number of entries in this database)
Fe(II) 217 Peroxidase (96), Cytochrome (ETC transmembrane protein) (49), Myoglobin (39), Catalase (23)
Zn(II) 192 Super oxide dismuatase (SOD) (39)
Ca(II) 113 Protein kinase (14), Hedgehog (13)
Mo(II) 98 Protein-methionine-sulfoxide reductase (Msr) (81), Aldehyde oxidase (10), Xanthine oxidase (7)
Mg(II) 57 ATP synthetase (21)
2Fe–2S 25 CDGSH iron–sulphur domain-containing protein (3), NADH-quinone oxidoreductase (2), Succinate dehydrogenase iron–sulphur subunit (2), Xanthine oxidase (7), Aldehyde oxidase (9)
Mn(II) 18 Super oxide dismutase (SOD) (6), Arginase (3)
K(I) 13 Ascorbate peroxidase (12)
4Fe–4S 5 NADH-quinone oxidoreductase (2), Succinate dehydrogenase iron–sulphur subunit (2)
Na(I) 3 P2X purinoceptor 7 (P2 × 7) (ATP receptor) (P2Z receptor) (Purinergic receptor) (3)
Ni(II) 3 Urease (3)
Cu(I) 1 Copper transfer ATPase (1)—ATP-driven copper [Cu(+)] ion pump

ROS interactions with cellular processes

As mentioned in the introduction, ROS has double effects on cellular processes, depending on the ROS concentrations, a) physiological concentration of ROS leads to ‘oxidative eustress’ and overproduction leads to cell damage, i.e. ‘oxidative distress’. Here, we discuss a specific example describing ROS interactions with cellular processes, mainly apoptosis and DNA damage via overexpression of the cellular tumour antigen p53 (tumour suppressor p53), UniProt ID: P67939. The possible mechanisms of p53-induced apoptosis include DNA damage [120], deregulation of oncogene expression [121], ribonucleotide depletion [122], hypoxia [123], oxidative stress [124], and ferroptosis [125, 126]. Over half of tumour patients have TP53 mutations. Ferroptosis, an emerging form of cell death, is associated with the accumulation of Fe(II) and ROS. Query search with this UniProt ID resulted in the interactome around the Tp53 protein (Fig. 10a). Mutations of this tumour oncogene trigger various cellular pathways; the factors, upregulated or downregulated in this process, are captured in this interactome and are shown (Fig. 10b). Mutated p53 suppresses anti-oxidant activity in the cell, exerting higher levels of ROS, i.e. oxidative distress [127]. Under physiological conditions, Tp53 level is very low, as it is continuously degraded by MDM2 protein [128]. Mutated Tp53 increases its inability to bind MDM2, thus expressing a tumour. MDM4 is a regulator of the p53 growth-arresting function, in contrast to MDM2, the p53 apoptotic function regulator. After DNA damage, MDM4 is downregulated by dissociation of deubiquitylating enzyme, USP, from the MDM4–MDM2. On a lethal type of stress, a fraction of MDM4 residing in mitochondria recruits phosphorylation of p53 on Ser46; the phosphorylated p53 interacts with BCL2 and ultimately releases cytochrome C; thus, MDM4 acts as a positive regulator of p53‐intrinsic apoptosis. Several other factors also interact with Tp53 and contribute towards tumour suppression. PTEN distantly regulates tumour suppression by inhibiting PI3K/Akt pathway [129]. Activated p53 upregulates cyclin dependent kinase inhibitor 1 A transcription [130, 131]. Thus, the database provides comprehensive interaction maps of different ROS-related proteins.

Figure 10.

Figure 10.

Interactome around Tp53, (a) derived from the STRING network and (b) regulatory pathways of Tp53; inhibition (—|) and interaction (→).

Retrieval of the information from the database

User-specific information is retrievable from the webserver ROSBase (https://rosbase.bits-hyderabad.ac.in/) using different keywords (such as a protein name, UniProt ID, PDB ID, cell organelle, or gene name). For example, if a user provides the query as UniProt ID ‘P00445,’ the programme will search the JSON file (database) and return the output, in a tabular form (Fig. 11). In case of a single entry, the output would return an interactome image, (generated by Cytoscape software) obtained from the STRING database [132]. The interactome image has potential use in deciphering genetic interactions, protein–protein interactions, signalling pathways etc.

Figure 11.

Figure 11.

Database example output against the query—UniProt ID: ‘P00445’; returned in a tabular format (upper panel). Cytoscape-generated interactome image (lower panel).

Browser and operating system testing

The web server was rigorously tested across several browsers, namely, Chrome, Firefox, and Safari, to check compatibility and performance consistency. The testing was done on different operating systems (OSs), namely, Windows, Linux, and macOS, ensuring that performances were independent of the platform. The web server was also optimized for mobile viewing, with responsive design, thus it worked independent of the device settings.

Long term database security and maintenance

To maintain, update, and sustain the database over time, scheduled data backups, performance monitoring via query profiling, and security updates are performed. For long-term database maintenance, scheduled backups and data retention for point-in-time recovery are performed. Regular upgradation and security patches are maintained to ensure security, compatibility, and the addition of new features. Dependencies, such as database drivers and libraries, are regularly updated to maintain compatibility and stability of the database. System sustainability and efficiency are maintained via the tools, such as, ‘Nginx’, the reverse proxy, ‘Gunicorn’, the process manager, and ‘Supervisor’, the automatic monitor for log generation, reporting errors, and uptime, server restart, etc.

Conclusion

ROS is an obligatory byproduct of various cellular processes across the taxonomic world which participate in both physiology and pathology. ROS-related information, such as ROS production, scavenging, regulation of several biochemical processes, diversity across the taxonomy, disease involvements etc., was scattered in the literature; however, those were not consolidated for ready reference. ROSBase1.0 is the first database of its kind that stores and disseminates ROS-related information. This database returns the following information in retrievable formats: (i) protein name, (ii) cell organelle, (iii) UniProt ID, (iv) PDB ID, (v) gene name, (vi) function, (vii) ROS-associated mechanism, (viii) diseases, and (ix) interactome image. The search keywords are any of the following: protein name, cell organelle, UniProt ID, PDB ID, and gene name. This database, for the first time, annotated the taxonomic world, diseases etc., in terms of their ROS-related activities. It has quantitatively highlighted that lower organisms contributed more towards ROS scavenging compared to ROS production. Within higher organisms, plants were more involved in ROS scavenging and ROS-directed physiology compared to ROS production. The role of ROS in various diseases was also quantified in this database. Three disease categories (anatomy-based) were maximally involved with ROS activities. This information gathered in the database has the potential utility towards better therapeutics for ROS-related diseases.

Acknowledgements

S.G. acknowledges Council of Scientific and Industrial Research (CSIR) India for funding junior and senior research fellowships (JRF/SRF); file no: 09/1026(0032)-2020-EMR-I. D.B. acknowledges Council of Scientific and Industrial Research (CSIR) India for funding this project; file no: 27(0360)/20/EMR-II.

Contributor Information

Sharayu Ghodeswar, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Hyderabad, Telangana, 500078, India.

Debashree Bandyopadhyay, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Hyderabad, Telangana, 500078, India.

Conflict of interest

None declared.

References

  • 1. Gerschman   R., Gilbert  D. L., Nye  S.W.  et al.  Oxygen poisoning and X-irradiation: A mechanism in common. Science. 1979;119 :623–6. doi: 10.1126/SCIENCE.119.3097.623 [DOI] [PubMed] [Google Scholar]
  • 2. Liu  Y, Zhao  H, Yin  K  et al.  The protective effect of Zn2+ on As3+ toxicity in common carp: resistance to oxidative stress, inhibition of endoplasmic reticulum stress, apoptosis and autophagy. Aquaculture. 2022;546:737375. 10.1016/j.aquaculture.2021.737375 [DOI] [Google Scholar]
  • 3. Nathan  C, Ding  A. Snapshot: reactive oxygen intermediates (ROI). Cell. 2010;140:951–.e2. 10.1016/j.cell.2010.03.008 [DOI] [PubMed] [Google Scholar]
  • 4. Mailloux  RJ. An update on mitochondrial reactive oxygen species production. Antioxidants. 2020;9:472. 10.3390/antiox9060472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Sies  H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613–19. 10.1016/j.redox.2016.12.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Sies  H, Berndt  C, Jones  DP. Oxidative stress. Annu Rev Biochem. 2017;86:715–48. 10.1146/annurev-biochem-061516-045037 [DOI] [PubMed] [Google Scholar]
  • 7. Klotz  LO, Steinbrenner  H. Cellular adaptation to xenobiotics: interplay between xenosensors, reactive oxygen species and foxo transcription factors. Redox Biol. 2017;13:646–54. 10.1016/j.redox.2017.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Schieber  M, Chandel  NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24:R453–62. 10.1016/j.cub.2014.03.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Reuter  S, Gupta  SC, Chaturvedi  MM  et al.  Oxidative stress, inflammation, and cancer: how are they linked?. Free Radical Biol Med. 2010;49:1603–16. 10.1016/j.freeradbiomed.2010.09.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Huang  PL. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab. 2009;20:295–302. 10.1016/j.tem.2009.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Zhang  L, Chen  C-L, Kang  PT  et al.  Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction. Biochemistry. 2010;49:2529–39. 10.1021/bi9018237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Papachristoforou  E, Lambadiari  V, Maratou  E  et al.  Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res. 2020;2020:1–17. 10.1155/2020/7489795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. McLennan  NF, Brennan  PM, McNeill  A  et al.  Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol. 2004;165:227–35. 10.1016/S0002-9440(10)63291-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Zhao  R–Z, Jiang  S, Zhang  L  et al.  Mitochondrial Electron Transport Chain, ROS Generation and Uncoupling (Review). Int J Mol Med. 2019;44:3–15. 10.3892/ijmm.2019.4188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Zorov  DB, Juhaszova  M, Sollott  SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94:909–50. 10.1152/physrev.00026.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Moya  M, López-Valencia  L, García-Bueno  B  et al.  Disinhibition-like behavior correlates with frontal cortex damage in an animal model of chronic alcohol consumption and thiamine deficiency. Biomedicines. 2022;10:260. 10.3390/biomedicines10020260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Yuan  Z, Ouyang  P, Gu  K  et al.  The antibacterial mechanism of oridonin against methicillin-resistant Staphylococcus aureus (MRSA). Pharm Biol. 2019;57:710–16. 10.1080/13880209.2019.1674342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hirschenson  J, Melgar-Bermudez  E, Mailloux  RJ. The uncoupling proteins: a systematic review on the mechanism used in the prevention of oxidative stress. Antioxidants. 2022;11:322. 10.3390/antiox11020322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Ma  M, Chambers  JK, Uchida  K  et al.  Effects of supplementation with a quebracho tannin product as an alternative to antibiotics on growth performance, diarrhea, and overall health in early-weaned piglets. Animals. 2021;11:3316. 10.3390/ani11113316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Chiarelli  N, Zoppi  N, Venturini  M  et al.  Matrix metalloproteinases inhibition by doxycycline rescues extracellular matrix organization and partly reverts myofibroblast differentiation in hypermobile Ehlers-Danlos syndrome dermal fibroblasts: a potential therapeutic target?. Cells. 2021;10:3236. 10.3390/cells10113236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Monteiro  BS, Freire-Brito  L, Carrageta  DF  et al.  Mitochondrial uncoupling proteins (UCPs) as key modulators of ros homeostasis: a crosstalk between diabesity and male infertility?. Antioxidants. 2021;10:1746. 10.3390/antiox10111746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Foth  BJ, Stimmler  LM, Handman  E  et al.  The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast. Mol Microbiol. 2005;55:39–53. 10.1111/j.1365-2958.2004.04407.x [DOI] [PubMed] [Google Scholar]
  • 23. Chalifoux  O, Faerman  B, Mailloux  RJ. Mitochondrial hydrogen peroxide production by pyruvate dehydrogenase and α-ketoglutarate dehydrogenase in oxidative eustress and oxidative distress. J Biol Chem. 2023;299:105399. 10.1016/j.jbc.2023.105399 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Onukwufor  JO, Berry  BJ, Wojtovich  AP. Physiologic implications of reactive oxygen species production by mitochondrial complex I reverse electron transport. Antioxidants. 2019;8:285. 10.3390/antiox8080285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Alberini  CM, Travaglia  A. Infantile amnesia: a critical period of learning to learn and remember. Journal Neurosci. 2017;37:5783–95. 10.1523/JNEUROSCI.0324-17.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Wang  J, Paesani  S, Ding  Y  et al.  Multidimensional quantum entanglement with large-scale integrated optics. Science. 2018;360:285–91. 10.1126/science.aar7053 [DOI] [PubMed] [Google Scholar]
  • 27. Görlach  A, Dimova  EY, Petry  A  et al.  Reactive oxygen species, nutrition, hypoxia and diseases: problems solved?, Redox Biol. 2015;6:372–85. 10.1016/j.redox.2015.08.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Phaniendra  A, Jestadi  DB, Periyasamy  L. Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases. India: Springer India. 2015. 10.1007/s12291-014-0446-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Vásquez-Vivar  J, Kalyanaraman  B, Kennedy  MC. Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem. 2000;275:14064–69. 10.1074/jbc.275.19.14064 [DOI] [PubMed] [Google Scholar]
  • 30. Wen  Y, Huo  F, Yin  C. Organelle targetable fluorescent probes for hydrogen peroxide. Chin Chem Lett. 2019;30:1834–42. 10.1016/j.cclet.2019.07.006 [DOI] [Google Scholar]
  • 31. Triantaphylidès  C, Havaux  M. Singlet oxygen in plants: production, detoxification and signaling. Trends Plant Sci. 2009;14:219–28. 10.1016/j.tplants.2009.01.008 [DOI] [PubMed] [Google Scholar]
  • 32. Shoute  LCT, Alfassi  ZB, Neta  P  et al.  Rate constants for reactions of (perhaloalkyl)peroxyl radicals with alkenes in methanol. J Phys Chem. 1994;98:5701–5704. 10.1021/j100073a021 [DOI] [Google Scholar]
  • 33. Bardaweel  SK, Gul  M, Alzweiri  M  et al.  Reactive oxygen species: the dual role in physiological and pathological conditions of the human body. Eurasian J Med. 2018;50:193–201. 10.5152/eurasianjmed.2018.17397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Jones  DP, Sies  H. The redox code. Antioxid Redox Signal. 2015;23:734–46. 10.1089/ars.2015.6247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Perkins  A, Nelson  KJ, Parsonage  D  et al.  Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci. 2015;40:435–45. 10.1016/j.tibs.2015.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Jara  M, Vivancos  AP, Calvo  IA  et al.  The peroxiredoxin Tpx1 is essential as a H2O2 scavenger during aerobic growth in fission yeast. Mol Biol Cell. 2007;18:2288–95. 10.1091/mbc.e06-11-1039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Turley  P, Walters  RK, Maghzian  O  et al.  Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat Genet. 2018;50:229–37. 10.1038/s41588-017-0009-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Zeisberger  M, Schmidt  MA. Erratum: author correction: analytic model for the complex effective index of the leaky modes of tube-type anti-resonant hollow core fibers (Scientific reports (2017) 7 1 (11761)). Sci Rep. 2018;8:1743. 10.1038/s41598-018-19722-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Stöcker  S, Maurer  M, Ruppert  T  et al.  A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation. Nat Chem Biol. 2018;14:148–55. 10.1038/nchembio.2536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Yang  K-S, Kang  SW, Woo  HA  et al.  Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem. 2002;277:38029–36. 10.1074/jbc.M206626200 [DOI] [PubMed] [Google Scholar]
  • 41. Rhee  SG, Woo  HA. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H2O2, and protein chaperones. Antioxid Redox Signal. 2011;15:781–94. 10.1089/ars.2010.3393 [DOI] [PubMed] [Google Scholar]
  • 42. Wood  ZA, Poole  LB, Karplus  PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science (1979). 2003;300:650–53. [DOI] [PubMed] [Google Scholar]
  • 43. Liu  W, Wu  H, Chen  L  et al.  Park7 interacts with p47 phox to direct NADPH oxidase-dependent ROS production and protect against sepsis. Cell Res. 2015;25:691–706. 10.1038/cr.2015.63 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Billings  EA, Lee  CS, Owen  KA  et al.  The adhesion GPCR BAI1 mediates macrophage ROS production and microbicidal activity against Gram-negative bacteria. Sci Signal. 2016;9. 10.1126/scisignal.aac6250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Zhang  J, Zhu  Q, Wang  X’e  et al.  Secretory kinase Fam20C tunes endoplasmic reticulum redox state via phosphorylation of Ero1α. EMBO J. 2018;37:e98699. 10.15252/embj.201798699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Jiménez  B, Volpert  OV, Crawford  SE  et al.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 2000;6:41–48. 10.1038/71517 [DOI] [PubMed] [Google Scholar]
  • 47. Simantov  R, Febbraio  M, Crombie  R  et al.  Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest. 2001;107:45–52. 10.1172/JCI9061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Asch  AS, Silbiger  S, Heimer  E  et al.  Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun. 1992;182:1208–17. 10.1016/0006-291X(92)91860-S [DOI] [PubMed] [Google Scholar]
  • 49. Cheung  CC, Clifton  DK, Steiner  RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 1997;138:4489–92. 10.1210/endo.138.10.5570 [DOI] [PubMed] [Google Scholar]
  • 50. Togo  SH, Maebuchi  M, Yokota  S  et al.  Immunological detection of alkaline-diaminobenzidine-negative peroxisomes of the nematode Caenorhabditis elegans Purification and unique pH optima of peroxisomal catalase. Eur J Biochem. 2000;267:1307–12. [DOI] [PubMed] [Google Scholar]
  • 51. Cuzzocrea  S, Reiter  RJ. Pharmacological action of melatonin in shock, inflammation and ischemiarreperfusion injury. Eur J Pharmacol. 2001;426:1–10. www.elsevier.comrlocaterejphar. 10.1016/s0014-2999(01)01175-x [DOI] [PubMed] [Google Scholar]
  • 52. Beckman  JS, Estévez  AG, Crow  JP  et al.  Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci. 2001;24:S15–20. 10.1016/S0166-2236(00)01981-0 [DOI] [PubMed] [Google Scholar]
  • 53. An  B, Li  B, Li  H  et al.  Aquaporin8 regulates cellular development and reactive oxygen species production, a critical component of virulence in Botrytis cinerea. New Phytol. 2016;209:1668–80. 10.1111/nph.13721 [DOI] [PubMed] [Google Scholar]
  • 54. Shen  W, Wei  Y, Dauk  M  et al.  Involvement of a glycerol-3-phosphate dehydrogenase in modulating the NADH/NAD+ ratio provides evidence of a mitochondrial glycerol-3-phosphate shuttle in Arabidopsis. Plant Cell. 2006;18:422–41. 10.1105/tpc.105.039750 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Qin  Z, Robichaud  P, He  T  et al.  Oxidant exposure induces cysteine-rich protein 61 (CCN1) via c-Jun/AP-1 to reduce collagen expression in human dermal fibroblasts. PLoS One. 2014;9:e115402. 10.1371/journal.pone.0115402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Jain  D, Weber  G, Eberhard  D  et al.  DJ-1 protects pancreatic beta cells from cytokine- and streptozotocin-mediated cell death. PLoS One. 2015;10:e0138535. 10.1371/journal.pone.0138535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Prasad  R, Chan  LF, Hughes  CR  et al.  Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab. 2014;99:E1556–63. 10.1210/jc.2013-3844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Sreelatha  A, Yee  SS, Lopez  VA  et al.  Protein AMPylation by an evolutionarily conserved pseudokinase. Cell. 2018;175:809–821.e19. 10.1016/j.cell.2018.08.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Girotto  S, Cendron  L, Bisaglia  M  et al.  DJ-1 Is a copper chaperone acting on SOD1 activation. J Biol Chem. 2014;289:10887–99. 10.1074/jbc.M113.535112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Ma  C, Haslbeck  M, Babujee  L  et al.  Identification and characterization of a stress-inducible and a constitutive small heat-shock protein targeted to the matrix of plant peroxisomes. Plant Physiol. 2006;141:47–60. 10.1104/pp.105.073841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Boggaram  V, Gottipati  KR, Wang  X  et al.  Early secreted antigenic target of 6 kDa (ESAT-6) protein of mycobacterium tuberculosis induces interleukin-8 (IL-8) expression in lung epithelial cells via protein kinase signaling and reactive oxygen species. J Biol Chem. 2013;288:25500–11. 10.1074/jbc.M112.448217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Thapa  RK, Soe  ZC, Ou  W  et al.  Palladium nanoparticle-decorated 2-D graphene oxide for effective photodynamic and photothermal therapy of prostate solid tumors. Colloids Surf B. 2018;169:429–37. 10.1016/j.colsurfb.2018.05.051 [DOI] [PubMed] [Google Scholar]
  • 63. Guo  H, Sadoul  R, Gibbings  D. Autophagy-independent effects of autophagy-related-5. (Atg5) on exosome production and metastasis. Mol Cell Oncol. 2018;5:e1445941. 10.1080/23723556.2018.1445941 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Cadenas  S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg. 2018;1859:940–50. 10.1016/j.bbabio.2018.05.019 [DOI] [PubMed] [Google Scholar]
  • 65. Mailloux  RJ, Jin  X, Willmore  WG. Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol. 2014;2:123–39. 10.1016/j.redox.2013.12.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Ruttkay-Nedecky  B, Nejdl  L, Gumulec  J  et al.  The role of metallothionein in oxidative stress. Int J Mol Sci. 2013;14:6044–66. 10.3390/ijms14036044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Cremers  CM, Jakob  U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem. 2013;288:26489–96. 10.1074/jbc.R113.462929 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Andrés  CMC, Pérez de la Lastra  JM, Andrés Juan  C  et al.  Impact of reactive species on amino acids—biological relevance in proteins and induced pathologies. Int J Mol Sci. 2022;23:14049. 10.3390/ijms232214049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Davies  MJ. The oxidative environment and protein damage. Biochim Biophys Acta (BBA)—Proteins Proteom. 2005;1703:93–109. 10.1016/j.bbapap.2004.08.007 [DOI] [PubMed] [Google Scholar]
  • 70. Collard  F, Vertommen  D, Constantinescu  S  et al.  Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase. J Biol Chem. 2011;286:38220–30. 10.1074/jbc.M111.287318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Nadtochiy  SM, Burwell  LS, Ingraham  CA  et al.  In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. J Mol Cell Cardiol. 2009;46:960–68. 10.1016/j.yjmcc.2009.01.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Tretter  L, Adam-Vizi  V. Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase. J Neurosci. 2004;24:7771–78. 10.1523/JNEUROSCI.1842-04.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Piantadosi  CA. Regulation of mitochondrial processes by protein S-nitrosylation. Biochim Biophys Acta (BBA)—Gen Subj. 2012;1820:712–21. 10.1016/j.bbagen.2011.03.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Mukherjee  S. Cysteine Modifications (oxPTM) and Protein Sulphenylation-Mediated Sulfenome Expression in Plants: Evolutionary Conserved Signaling Networks?. Plant Signal Behav. 2021;16:1831792. 10.1080/15592324.2020.1831792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Roos  G, Messens  J. Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radical Biol Med. 2011;51:314–26. 10.1016/j.freeradbiomed.2011.04.031 [DOI] [PubMed] [Google Scholar]
  • 76. Chung  HS, Wang  S-B, Venkatraman  V  et al.  Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res. 2013;112:382–92. 10.1161/CIRCRESAHA.112.268680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Sun  Y, Lu  Y, Saredy  J  et al.  ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes. Redox Biol. 2020;37:101696. 10.1016/j.redox.2020.101696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Yoboue  ED, Sitia  R, Simmen  T. Redox Crosstalk at Endoplasmic Reticulum (ER) Membrane Contact Sites (MCS) Uses Toxic Waste to Deliver Messages. Cell Death Dis. 2018;9:331. 10.1038/s41419-017-0033-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Rusiñol  AE, Cui  Z, Chen  MH  et al.  A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J Biol Chem. 1994;269:27494–502. 10.1016/S0021-9258(18)47012-3 [DOI] [PubMed] [Google Scholar]
  • 80. Wanders  RJA, Waterham  HR, Ferdinandusse  S. Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum. Front Cell Dev Biol. 2016;3. 10.3389/fcell.2015.00083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Sinenko  SA, Starkova  TY, Kuzmin  AA  et al.  Physiological signaling functions of reactive oxygen species in stem cells: fromf lies to man. Front Cell Dev Biol. 2021;9:71437. 10.3389/fcell.2021.714370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Raimondi  V, Ciccarese  F, Ciminale  V. Oncogenic pathways and the electron transport chain: a dangeROS liaison. Br J Cancer. 2020;122:168–81. 10.1038/s41416-019-0651-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Lee  S, Cheng  H, King  KE  et al.  Gibberellin regulates Arabidopsis seed germination via RGL2, a GAI/RGA-like gene whose expression is up-regulated following imbibition. Genes Dev. 2002;16:646–58. 10.1101/gad.969002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Schoch  CL, Ciufo  S, Domrachev  M  et al.  NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database. 2020;2020:baaa062. 10.1093/database/baaa062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Sayers  EW, Cavanaugh  M, Clark  K  et al.  GenBank. Nucleic Acids Res. 2019;47:D94–99. 10.1093/nar/gky989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Hou  S, Liu  D, Huang  S  et al.  The Arabidopsis MIK2 receptor elicits immunity by sensing a conserved signature from phytocytokines and microbes. Nat Commun. 2021;12:5494. 10.1038/s41467-021-25580-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Zhou  Y, Yu  H, Tang  Y  et al.  Critical roles of mitochondrial fatty acid synthesis in tomato development and environmental response. Plant Physiol. 2022;190:576–91. 10.1093/plphys/kiac255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Tripathy  BC, Oelmüller  R. Reactive oxygen species generation and signaling in plants. Plant Signal Behav. 2012;7:1621–33. 10.4161/psb.22455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Zhao  X, Drlica  K. Reactive oxygen species and the bacterial response to lethal stress. Curr Opin Microbiol. 2014;21:1–6. 10.1016/j.mib.2014.06.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Noctor  G, Reichheld  JP, Foyer  CH. ROS-related redox regulation and signaling in plants. Semin Cell Dev Biol. 2018;80:3–12. 10.1016/j.semcdb.2017.07.013 [DOI] [PubMed] [Google Scholar]
  • 91. Esterházy  D, King  MS, Yakovlev  G  et al.  Production of reactive oxygen species by complex I (NADH:ubiquinone oxidoreductase) from Escherichia coli and comparison to the enzyme from mitochondria. Biochemistry. 2008;47:3964–71. 10.1021/bi702243b [DOI] [PubMed] [Google Scholar]
  • 92. Ma  X, Wei  H, Zhang  Y  et al.  Glutathione peroxidase 5 deficiency induces lipid metabolism regulated by reactive oxygen species in Chlamydomonas reinhardtii. Microb Pathog. 2020;147:104358. 10.1016/j.micpath.2020.104358 [DOI] [PubMed] [Google Scholar]
  • 93. Cheong  AWY, Lee  Y-L, Liu  W-M  et al.  Oviductal microsomal epoxide hydrolase (EPHX1) reduces reactive oxygen species (ROS) level and enhances preimplantation mouse embryo development. Biol Reprod. 2009;81:126–32. 10.1095/biolreprod.108.071449 [DOI] [PubMed] [Google Scholar]
  • 94. Migita  T, Okabe  S, Ikeda  K  et al.  Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact. Am J Pathol. 2013;182:1800–10. 10.1016/j.ajpath.2013.01.048 [DOI] [PubMed] [Google Scholar]
  • 95. Trevelin  S, Lopes  L. Protein disulfide isomerase and Nox: new partners in redox signaling. Curr Pharm Des. 2015;21:5951–63. 10.2174/1381612821666151029112523 [DOI] [PubMed] [Google Scholar]
  • 96. Wolyniec  K, Levav-Cohen  Y, Jiang  Y-H  et al.  The E6AP E3 ubiquitin ligase regulates the cellular response to oxidative stress. Oncogene. 2013;32:3510–19. 10.1038/onc.2012.365 [DOI] [PubMed] [Google Scholar]
  • 97. Kuroda  Y, Sako  W, Goto  S  et al.  Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential. Hum Mol Genet. 2012;21:991–1003. 10.1093/hmg/ddr530 [DOI] [PubMed] [Google Scholar]
  • 98. Ding  S, Zhang  B, Qin  F. Arabidopsis rzfp34/chyr1, a ubiquitin e3 ligase, regulates stomatal movement and drought tolerance viasnrk2.6-mediated phosphorylation. Plant Cell. 2015;27:3228–44. 10.1105/tpc.15.00321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Kim  EH, Koh  EH, Park  J-Y  et al.  Adenine nucleotide translocator as a regulator of mitochondrial function: implication in the pathogenesis of metabolic syndrome. Korean Diab J. 2010;34:146. 10.4093/kdj.2010.34.3.146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Zhikrivetskaya  SO, Snezhkina  AV, Zaretsky  AR  et al.  Molecular markers of paragangliomas/pheochromocytomas. Oncotarget. 2017;8:25756–82. 10.18632/oncotarget.15201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Reula  A, Castillo-Corullón  S, Armengot  M  et al.  Redox imbalance in nasal epithelial cells of primary ciliary dyskinesia patients. Antioxidants. 2024;13:190. 10.3390/antiox13020190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Vabres  P, Sorlin  A, Kholmanskikh  SS  et al.  Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome. Nat Genet. 2019;51:1438–41. 10.1038/s41588-019-0498-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Iqbal  K, del C. Alonso  A, Chen  S  et al.  Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta (BBA)—Mol Basis Dis. 2005;1739:198–210. 10.1016/j.bbadis.2004.09.008 [DOI] [PubMed] [Google Scholar]
  • 104. Wardega  P, Heldin  CH, Lennartsson  J. Mutation of tyrosine residue 857 in the PDGF β-receptor affects cell proliferation but not migration. Cell Signal. 2010;22:1363–68. 10.1016/j.cellsig.2010.05.004 [DOI] [PubMed] [Google Scholar]
  • 105. Mendelson  K, Swendeman  S, Saftig  P  et al.  Stimulation of platelet-derived growth factor receptor β (PDGFRβ) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRβ and Epidermal Growth Factor Receptor (EGFR) signaling pathways. J Biol Chem. 2010;285:25024–32. 10.1074/jbc.M110.102566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Schell  C, Wanner  N, Huber  TB. Glomerular development—shaping the multi-cellular filtration unit. Semin Cell Dev Biol. 2014;36:39–49. 10.1016/j.semcdb.2014.07.016 [DOI] [PubMed] [Google Scholar]
  • 107. Gilbertson  DG, Duff  ME, West  JW  et al.  Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor. J Biol Chem. 2001;276:27406–14. 10.1074/jbc.M101056200 [DOI] [PubMed] [Google Scholar]
  • 108. Klion  AD, Robyn  J, Akin  C  et al.  Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood. 2004;103:473–78. 10.1182/blood-2003-08-2798 [DOI] [PubMed] [Google Scholar]
  • 109. Arts  FA, Velghe  AI, Stevens  M  et al.  Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling. J Cell Mol Med. 2015;19:239–48. 10.1111/jcmm.12443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Dachy  G, de Krijger  RR, Fraitag  S  et al.  Association of PDGFRB mutations with pediatric myofibroma and myofibromatosis. JAMA Dermatol. 2019;155:946–50. 10.1001/jamadermatol.2019.0114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Hettmer  S, Dachy  G, Seitz  G  et al.  Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group. Fam Cancer. 2021;20:327–36. 10.1007/s10689-020-00204-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Paulsen  CE, Carroll  KS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev. 2013;113:4633–79. 10.1021/cr300163e [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Kumar  S, Bhardwaj  VK, Guleria  S  et al.  Improving the catalytic efficiency and dimeric stability of Cu,Zn superoxide dismutase by combining structure-guided consensus approach with site-directed mutagenesis. Biochim Biophys Acta (BBA)—Bioenerg. 2022;1863:148505. 10.1016/j.bbabio.2021.148505 [DOI] [PubMed] [Google Scholar]
  • 114. Ushimaru  T, Maki  Y, Sano  S  et al.  Induction of enzymes involved in the ascorbate-dependent antioxidative system, namely, ascorbate peroxidase, monodehydroascorbate reductase and dehydroascorbate reductase, after exposure to air of rice (Oryza sativa) seedlings germinated under water. Plant Cell Physiol. 1997;38:541–49. http://pcp.oxfordjournals.org/  (24 August 2025, date last accessed) [Google Scholar]
  • 115. Noctor  G, Veljovic-Jovanovic  S, Foyer  CH. Peroxide processing in photosynthesis: antioxidant coupling and redox signalling. Philos Trans R Soc Lond B Biol Sci. 2000;355:1465–75. 10.1098/RSTB.2000.0707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116. Rulíšek  L, Jensen  KP, Lundgren  K  et al.  The reaction mechanism of iron and manganese superoxide dismutases studied by theoretical calculations. J Comput Chem. 2006;27:1398–414. 10.1002/JCC.20450 [DOI] [PubMed] [Google Scholar]
  • 117. Adamus  JP, Ruszczyńska  A, Wyczałkowska-Tomasik  A. Molybdenum’s role as an essential element in enzymes catabolizing redox reactions: a review. Biomolecules. 2024;14:869. 10.3390/BIOM14070869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Lee  BC, Gladyshev  VN. The biological significance of methionine sulfoxide stereochemistry. Free Radical Biol Med. 2011;50:221–27. 10.1016/j.freeradbiomed.2010.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Read  AD, Bentley  RE, Archer  SL  et al.  Mitochondrial iron–sulfur clusters: structure, function, and an emerging role in vascular biology. Redox Biol. 2021;47:102164. 10.1016/J.REDOX.2021.102164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Lowe  SW, Schmitt  EM, Smith  SW  et al.  P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847–49. 10.1038/362847A0 [DOI] [PubMed] [Google Scholar]
  • 121. Hermeking  H, Eick  D. Mediation of c-Myc-induced apoptosis by p53. Science. 1994;265:2091–93. 10.1126/SCIENCE.8091232 [DOI] [PubMed] [Google Scholar]
  • 122. Gottlieb  TM, Oren  M. p53 and apoptosis. Semin Cancer Biol. 1998;8:359–68. 10.1006/SCBI.1998.0098 [DOI] [PubMed] [Google Scholar]
  • 123. Graeber  TG, Osmanian  C, Jacks  T  et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88–91. 10.1038/379088A0 [DOI] [PubMed] [Google Scholar]
  • 124. Yin  Y  et al.  Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature. 1998;391:707–10. 10.1038/35648;KWRD=SCIENCE [DOI] [PubMed] [Google Scholar]
  • 125. Jiang  L, Kon  N, Li  T  et al.  Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62. 10.1038/nature14344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126. Gao  Q, Chen  J-M, Li  C-S-Z  et al.  CDKN1A promotes Cis-induced AKI by inducing cytoplasmic ROS production and ferroptosis. Food Chem Toxicol. 2024;193:115003. 10.1016/J.FCT.2024.115003 [DOI] [PubMed] [Google Scholar]
  • 127. Cordani  M, Butera  G, Pacchiana  R  et al.  Mutant p53-associated molecular mechanisms of ROS regulation in cancer cells. Biomolecules. 2020;10:361. 10.3390/BIOM10030361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. Mancini  F  et al.  MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J. 2009;28:1926–39. 10.1038/EMBOJ.2009.154/SUPPL_FILE/EMBJ2009154-SUP-0008.DOC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129. Trinh  VH, Nguyen Huu  T, Sah  DK  et al.  Redox regulation of PTEN by reactive oxygen species: its role in physiological processes. Antioxidants. 2024;13:199. 10.3390/ANTIOX13020199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130. Wang  H, Liu  C, Jiang  H  et al.  A laboratory experiment on preparation of 3PbO·PbSO4·H2O using less solvent solid state reaction for undergraduate students. Educ Chem Eng. 2023;43:92–99. 10.1016/J.ECE.2023.02.003 [DOI] [Google Scholar]
  • 131. Hernández Borrero  LJ, El-Deiry  WS. Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta (BBA)—Rev Cancer. 2021;1876:188556. 10.1016/J.BBCAN.2021.188556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Szklarczyk  D, Franceschini  A, Wyder  S  et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52. 10.1093/nar/gku1003 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Database: The Journal of Biological Databases and Curation are provided here courtesy of Oxford University Press

RESOURCES